Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cloning and Mutagenesis Market to reach USD 7.88 billion by the end of 2029

Global Cloning and Mutagenesis Market Size study & Forecast, by Product (Cloning Kits, Mutagenesis Kits), By Technology (Topo PCR Cloning, Blunt End Cloning Seamless Cloning, Site-Directed Mutagenesis, Others), By End user (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes ), and Regional Analysis, 2022-2029

Product Code: HLSB-19330256
Publish Date: 20-03-2023
Page: 200

Global Cloning and Mutagenesis Market is valued at approximately USD 2.00 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.7% over the forecast period 2022-2029. Cloning is the process of creating naturally occurring or artificially produced, genetically identical copies of an organism. Mutagenesis is the process through which an organism’s genetic composition is altered, leading to a mutation. In a laboratory context, mutagenesis is carried out when DNA is intentionally modified to produce mutant proteins, genes, or strains of an organism. Cloning and mutagenesis are two of the most effective methods created to research the links between protein structure and function. They are used to confirm the effects of mutations both in vitro and in vivo. Due to the growing use of cloning in numerous genetic applications, such as reproductive cloning, the global cloning and mutagenesis industry is expected to rise. The prevalence of hereditary and chronic diseases is expected to increase, as is the demand for personalized medicine. Due to growing financing for research and development targeted at curing genetic issues and other diseases, such as cancer and HIV, cloning and mutagenesis technologies are becoming more and more necessary.

The primary factors driving the global market are the rise in the prevalence of hereditary and chronic diseases, the rise in demand for personalized medicine, and the rise in new companies entering the industry. The industry’s expansion is further aided by favorable funding conditions for gene synthesis and cloning services, technological advancements in the cloning industry, and an increase in commercial activities that work together well. Innovative, effective DNA and gene cloning services are being developed by top industry players. According to statista, nearly 17.9 million people worldwide passed away in 2019 as a result of cardiovascular disorders of all kinds. The number of deaths worldwide in 2019 attributable to a few chronic diseases is shown in this data. Chronic illness has negative effects on people’s quality of life and lifespan, as well as on society and governments around the world. An enhancement in research and development can open up many opportunities. However, the side effects of cloning and mutation are restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Cloning and Mutagenesis Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, additionally, Cloning and mutagenesis methods are now used more frequently in the region as platforms built on genomic and proteomic data become more widely accepted. Greater product penetration in the region is due to the presence of top inventors and market players. In May 2021, Telesis Bio, Inc., a U.S. company, announced, for instance, that its BioXp technology now offers lengthy fragment cloning. With the help of this project, researchers may overnight hand-free clone into custom vectors and produce multivariant, error-corrected vectors.

Major market players included in this report are:

Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
New England Biolabs Inc.
Takara Bio Inc.
Merck KGaA
Promega Corporation
Bio-Rad Laboratories, Inc.
Danaher Corporation
Jena Bioscience GmbH
Assay Genie

Recent Developments in the Market:
 In May 2021, the American company Telesis Bio, Inc. announced long fragment cloning is now supported by its BioXp technology. This project enables researchers to build multivariant, error-corrected vectors and hand-free overnight clone them into custom vectors.
 In June 2019, The Human Glycome Project, a global endeavour to map the composition and function of human glycans, was announced by NEB, Waters, and Genos as a collaboration. To help with better sample preparation and process throughput, NEB will provide a variant of their Rapid PNGase F technology. In order to give its consumers access to illustrations of how its products are used in actual situations, NEB partnered with the artificial intelligence technology firm Bioz, Inc. in the same month.

Global Cloning and Mutagenesis Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Technology, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Cloning Kits
Mutagenesis Kits

By Technology:
Topo PCR Cloning
Blunt End Cloning
Seamless Cloning
Site-directed Mutagenesis
Others

By End User:
Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Cloning and Mutagenesis Market, by Region, 2019-2029 (USD Billion)
1.2.2. Cloning and Mutagenesis Market, by Product, 2019-2029 (USD Billion)
1.2.3. Cloning and Mutagenesis Market, by Technology, 2019-2029 (USD Billion)
1.2.4. Cloning and Mutagenesis Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cloning and Mutagenesis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cloning and Mutagenesis Market Dynamics
3.1. Cloning and Mutagenesis Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing need for customised medicine
3.1.1.2. rise in the frequency of inherited and chronic illnesses
3.1.1.3. the growth in new businesses entering the market
3.1.2. Market Challenges
3.1.2.1 The market growth is being constrained by the negative consequences of causing genetic disorder or cancer.
3.1.3. Market Opportunities
3.1.3.1. Increase in research & development
3.1.3.2. Higher developments and recent advancements towards the formulation.
Chapter 4. Global Cloning and Mutagenesis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cloning and Mutagenesis Market, by Product
6.1. Market Snapshot
6.2. Global Cloning and Mutagenesis Market by Product ,Performance – Potential Analysis
6.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by Product2019-2029 (USD Billion)
6.4. Cloning and Mutagenesis Market, Sub Segment Analysis
6.4.1. Cloning kits
6.4.2. Mutagenesis kits
Chapter 7. Global Cloning and Mutagenesis Market, by Technology
7.1. Market Snapshot
7.2. Global Cloning and Mutagenesis Market by Technology, Performance – Potential Analysis
7.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
7.4. Cloning and Mutagenesis Market, Sub Segment Analysis
7.4.1. Topo PCR Cloning
7.4.2. Blunt End Cloning
7.4.3. Seamless Cloning
7.4.4. Site directed Cloning
7.4.5. Others
Chapter 8. Global Cloning and Mutagenesis Market, by End User
8.1. Market Snapshot
8.2. Global Cloning and Mutagenesis Market by End user, Performance – Potential Analysis
8.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
8.4. Cloning and Mutagenesis Market, Sub Segment Analysis
8.4.1. Biopharmaceutical & Pharmaceutical companies
8.4.2. CROs & CMOs
8.4.3. Academic & Research Institutes
Chapter 9. Global Cloning and Mutagenesis Market, Regional Analysis
9.1. Cloning and Mutagenesis Market, Regional Market Snapshot
9.2. North America Cloning and Mutagenesis Market
9.2.1. U.S. Cloning and Mutagenesis Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. End user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Cloning and Mutagenesis Market
9.3. Europe Cloning and Mutagenesis Market Snapshot
9.3.1. U.K. Cloning and Mutagenesis Market
9.3.2. Germany Cloning and Mutagenesis Market
9.3.3. France Cloning and Mutagenesis Market
9.3.4. Spain Cloning and Mutagenesis Market
9.3.5. Italy Cloning and Mutagenesis Market
9.3.6. Rest of Europe Cloning and Mutagenesis Market
9.4. Asia-Pacific Cloning and Mutagenesis Market Snapshot
9.4.1. China Cloning and Mutagenesis Market
9.4.2. India Cloning and Mutagenesis Market
9.4.3. Japan Cloning and Mutagenesis Market
9.4.4. Australia Cloning and Mutagenesis Market
9.4.5. South Korea Cloning and Mutagenesis Market
9.4.6. Rest of Asia Pacific Cloning and Mutagenesis Market
9.5. Latin America Cloning and Mutagenesis Market Snapshot
9.5.1. Brazil Cloning and Mutagenesis Market
9.5.2. Mexico Cloning and Mutagenesis Market
9.5.3. Rest of Latin America Cloning and Mutagenesis Market
9.6. Rest of The World Cloning and Mutagenesis Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Agilent Technologies, Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Agilent Technologies, Inc
10.2.3. New England Biolabs Inc.
10.2.4. Takara Bio Inc.
10.2.5. Merck KGaA
10.2.6. Promega Corporation
10.2.7. Bio-Rad Laboratories Inc.
10.2.8. Danaher Corporation
10.2.9. Jena Bioscience GmbH
10.2.10. Assay Genie
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now